Related Experiment Video
Updated: Jul 12, 2026
13:45
Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
Published on: April 27, 2011
Incorporating novel virologic tests into clinical practice
1Harbor-University of California Los Angeles Medical Center, CA, USA.
Summary
Evolving virologic assays are crucial for managing HIV infection. Current tests struggle to detect minority resistant variants, impacting treatment success and highlighting the need for optimized antiretroviral therapy to prevent virologic failure.
Area of Science:
- * Medical diagnostics and virology.
- * HIV/AIDS research and treatment.
Background:
- * Virologic assays are essential tools for managing HIV-infected patients.
- * Existing genotypic and phenotypic assays for antiretroviral drug resistance have limitations.
- * The emergence of drug resistance is a significant challenge in HIV treatment.
Purpose of the Study:
- * To review the current state and evolving landscape of virologic assays for HIV management.
- * To discuss the clinical implications of detecting minority resistant variants.
- * To highlight the role of emerging assays in guiding treatment decisions for novel antiretroviral agents.
Main Methods:
- * Summary of a presentation on viral assays.
- * Review of genotypic, phenotypic, and tropism assays.
- * Discussion of clinical data and emerging trends in HIV virology.
Main Results:
- * Genotypic and phenotypic assays have defined roles but also limitations, particularly in detecting minority resistant variants.
- * Failure to detect minority resistant variants is linked to an increased risk of virologic failure.
- * HIV coreceptor tropism assays are critical for the use of coreceptor antagonists.
- * All antiretroviral drugs can select for resistance, necessitating optimized background therapy.
Conclusions:
- * Advancements in virologic assays are vital for effective HIV patient care.
- * Detecting minority resistant variants and understanding viral fitness are key areas for future assay development.
- * Optimized background therapy is crucial to prevent virologic failure when using antiretroviral drugs.
Related Concept Videos
01:24Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...